INS and diabetes mellitus: Therefore, GNPs has opened up the way for a novel therapeutic agent for the management of diabetes and its complications via (1) enhancing the antioxidant defense enzymes and performing a maintained control across the hyperglycemic condition and (2) delivery and prolonging insulin activity for reducing the frequency of insulin injection (Figure 3B).